Journal article
Hepatitis C transmission and treatment as prevention - The role of the injecting network
M Hellard, E McBryde, R Sacks Davis, DA Rolls, P Higgs, C Aitken, A Thompson, J Doyle, P Pattison, G Robins
International Journal of Drug Policy | Published : 2015
Abstract
Background: The hepatitis C virus (HCV) epidemic is a major health issue; in most developed countries it is driven by people who inject drugs (PWID). Injecting networks powerfully influence HCV transmission. In this paper we provide an overview of 10 years of research into injecting networks and HCV, culminating in a network-based approach to provision of direct-acting antiviral therapy. Methods: Between 2005 and 2010 we followed a cohort of 413 PWID, measuring HCV incidence, prevalence and injecting risk, including network-related factors. We developed an individual-based HCV transmission model, using it to simulate the spread of HCV through the empirical social network of PWID. In addition..
View full abstractGrants
Awarded by Gilead Sciences
Funding Acknowledgements
MH, EMc, RSD and JD acknowledge fellowship support from the National Health and Medical Research Council. PH is supported by a Curtin University Fellowship. The authors acknowledge the contribution to this work of support from the NHMRC (App-331312 and App-1001144), the ARC (App DP0987730) and the Victorian Operational Infrastructure Support Program (Department of Health, Victoria, Australia) to the Burnet Institute.